- Home
- QSG vs CRVO Comparison
QSG vs CRVO Comparison
Compare QSG & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QSG
- CRVO
- Stock Information
- Founded
- QSG 2019
- CRVO 2001
- Country
- QSG China
- CRVO United States
- Employees
- QSG N/A
- CRVO N/A
- Industry
- QSG Other Consumer Services
- CRVO Biotechnology: Pharmaceutical Preparations
- Sector
- QSG Real Estate
- CRVO Health Care
- Exchange
- QSG Nasdaq
- CRVO Nasdaq
- Market Cap
- QSG 121.6M
- CRVO 98.3M
- IPO Year
- QSG 2023
- CRVO N/A
- Fundamental
- Price
- QSG $2.35
- CRVO $2.26
- Analyst Decision
- QSG
- CRVO Buy
- Analyst Count
- QSG 0
- CRVO 8
- Target Price
- QSG N/A
- CRVO $38.75
- AVG Volume (30 Days)
- QSG 113.2K
- CRVO 161.1K
- Earning Date
- QSG 03-06-2025
- CRVO 11-12-2024
- Dividend Yield
- QSG 8.63%
- CRVO N/A
- EPS Growth
- QSG 662.58
- CRVO N/A
- EPS
- QSG 1.03
- CRVO N/A
- Revenue
- QSG $532,696,414.00
- CRVO $10,066,550.00
- Revenue This Year
- QSG N/A
- CRVO $34.17
- Revenue Next Year
- QSG N/A
- CRVO N/A
- P/E Ratio
- QSG $2.32
- CRVO N/A
- Revenue Growth
- QSG 13.53
- CRVO 116.29
- 52 Week Low
- QSG $1.47
- CRVO $1.80
- 52 Week High
- QSG $6.22
- CRVO $26.38
- Technical
- Relative Strength Index (RSI)
- QSG 53.97
- CRVO 34.18
- Support Level
- QSG $2.29
- CRVO $2.15
- Resistance Level
- QSG $2.48
- CRVO $2.38
- Average True Range (ATR)
- QSG 0.20
- CRVO 0.13
- MACD
- QSG 0.04
- CRVO 0.22
- Stochastic Oscillator
- QSG 75.02
- CRVO 71.05
About QSG QuantaSing Group Limited
QuantaSing Group Ltd is a learning service provider in China's adult learning market for personal interest courses. It offers easy-to-understand, affordable, and accessible online courses to adult learners under various brands, including QiNiu, Kelly, and QianChi among others empowering them to pursue personal development. The company offers courses for various domains such as financial literacy, skill upgrading, recreation, and leisure which are offered in live large-class dual-instructor mode, online community-based training camp mode, and in live lecture, one-on-one tutoring mode. Its segments are; Learning service and others which derives key revenue, and Consumer business. Geographically, the company generates all of its revenue from the People's Republic of China.
About CRVO CervoMed Inc.
CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.